Project
Illumina Body Map 2: averaged replicates
Navigation
Downloads
Results for TFDP1
Z-value: 2.64
Motif logo
Transcription factors associated with TFDP1
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
TFDP1
|
ENSG00000198176.8 | transcription factor Dp-1 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| TFDP1 | hg19_v2_chr13_+_114239588_114239752 | 0.16 | 3.9e-01 | Click! |
Activity profile of TFDP1 motif
Sorted Z-values of TFDP1 motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr5_+_133450365 | 8.01 |
ENST00000342854.5
ENST00000321603.6 ENST00000321584.4 ENST00000378564.1 ENST00000395029.1 |
TCF7
|
transcription factor 7 (T-cell specific, HMG-box) |
| chr1_-_111217603 | 6.73 |
ENST00000369769.2
|
KCNA3
|
potassium voltage-gated channel, shaker-related subfamily, member 3 |
| chrX_-_129244655 | 5.00 |
ENST00000335997.7
|
ELF4
|
E74-like factor 4 (ets domain transcription factor) |
| chr12_+_94542459 | 4.64 |
ENST00000258526.4
|
PLXNC1
|
plexin C1 |
| chr17_+_45810594 | 4.62 |
ENST00000177694.1
|
TBX21
|
T-box 21 |
| chr5_+_133451254 | 4.48 |
ENST00000517851.1
ENST00000521639.1 ENST00000522375.1 ENST00000378560.4 ENST00000432532.2 ENST00000520958.1 ENST00000518915.1 ENST00000395023.1 |
TCF7
|
transcription factor 7 (T-cell specific, HMG-box) |
| chrX_-_129244454 | 4.36 |
ENST00000308167.5
|
ELF4
|
E74-like factor 4 (ets domain transcription factor) |
| chr2_+_74212073 | 4.08 |
ENST00000441217.1
|
AC073046.25
|
AC073046.25 |
| chr1_+_27022839 | 3.91 |
ENST00000457599.2
|
ARID1A
|
AT rich interactive domain 1A (SWI-like) |
| chr17_-_61777459 | 3.87 |
ENST00000578993.1
ENST00000583211.1 ENST00000259006.3 |
LIMD2
|
LIM domain containing 2 |
| chrX_-_129244336 | 3.81 |
ENST00000434609.1
|
ELF4
|
E74-like factor 4 (ets domain transcription factor) |
| chr5_+_176853669 | 3.67 |
ENST00000355472.5
|
GRK6
|
G protein-coupled receptor kinase 6 |
| chr6_+_135502501 | 3.55 |
ENST00000527615.1
ENST00000420123.2 ENST00000525369.1 ENST00000528774.1 ENST00000534121.1 ENST00000534044.1 ENST00000533624.1 |
MYB
|
v-myb avian myeloblastosis viral oncogene homolog |
| chr1_+_27022485 | 3.23 |
ENST00000324856.7
|
ARID1A
|
AT rich interactive domain 1A (SWI-like) |
| chr17_+_37026106 | 3.14 |
ENST00000318008.6
|
LASP1
|
LIM and SH3 protein 1 |
| chr5_+_176853702 | 3.12 |
ENST00000507633.1
ENST00000393576.3 ENST00000355958.5 ENST00000528793.1 ENST00000512684.1 |
GRK6
|
G protein-coupled receptor kinase 6 |
| chr17_+_37026284 | 3.12 |
ENST00000433206.2
ENST00000435347.3 |
LASP1
|
LIM and SH3 protein 1 |
| chr17_-_61777090 | 2.94 |
ENST00000578061.1
|
LIMD2
|
LIM domain containing 2 |
| chr8_-_67525524 | 2.89 |
ENST00000517885.1
|
MYBL1
|
v-myb avian myeloblastosis viral oncogene homolog-like 1 |
| chr11_-_46142948 | 2.88 |
ENST00000257821.4
|
PHF21A
|
PHD finger protein 21A |
| chr17_-_73179046 | 2.85 |
ENST00000314523.7
ENST00000420826.2 |
SUMO2
|
small ubiquitin-like modifier 2 |
| chrY_+_2803322 | 2.81 |
ENST00000383052.1
ENST00000155093.3 ENST00000449237.1 ENST00000443793.1 |
ZFY
|
zinc finger protein, Y-linked |
| chr14_-_91884150 | 2.71 |
ENST00000553403.1
|
CCDC88C
|
coiled-coil domain containing 88C |
| chr9_-_110251836 | 2.70 |
ENST00000374672.4
|
KLF4
|
Kruppel-like factor 4 (gut) |
| chr19_-_10679644 | 2.67 |
ENST00000393599.2
|
CDKN2D
|
cyclin-dependent kinase inhibitor 2D (p19, inhibits CDK4) |
| chr1_+_43148625 | 2.67 |
ENST00000436427.1
|
YBX1
|
Y box binding protein 1 |
| chr17_+_42634844 | 2.62 |
ENST00000315323.3
|
FZD2
|
frizzled family receptor 2 |
| chr5_+_53813536 | 2.57 |
ENST00000343017.6
ENST00000381410.4 ENST00000326277.3 |
SNX18
|
sorting nexin 18 |
| chr9_-_37034028 | 2.56 |
ENST00000520281.1
ENST00000446742.1 ENST00000522003.1 ENST00000523145.1 ENST00000414447.1 ENST00000377847.2 ENST00000377853.2 ENST00000377852.2 ENST00000523241.1 ENST00000520154.1 ENST00000358127.4 |
PAX5
|
paired box 5 |
| chr14_-_99737822 | 2.50 |
ENST00000345514.2
ENST00000443726.2 |
BCL11B
|
B-cell CLL/lymphoma 11B (zinc finger protein) |
| chrX_+_64887512 | 2.48 |
ENST00000360270.5
|
MSN
|
moesin |
| chr17_+_54671047 | 2.47 |
ENST00000332822.4
|
NOG
|
noggin |
| chr17_+_38474489 | 2.45 |
ENST00000394089.2
ENST00000425707.3 |
RARA
|
retinoic acid receptor, alpha |
| chr8_-_67525473 | 2.42 |
ENST00000522677.3
|
MYBL1
|
v-myb avian myeloblastosis viral oncogene homolog-like 1 |
| chr11_-_46142615 | 2.41 |
ENST00000529734.1
ENST00000323180.6 |
PHF21A
|
PHD finger protein 21A |
| chr1_+_100818009 | 2.40 |
ENST00000370125.2
ENST00000361544.6 ENST00000370124.3 |
CDC14A
|
cell division cycle 14A |
| chr6_-_91006461 | 2.39 |
ENST00000257749.4
ENST00000343122.3 ENST00000406998.2 ENST00000453877.1 |
BACH2
|
BTB and CNC homology 1, basic leucine zipper transcription factor 2 |
| chr17_+_43299241 | 2.39 |
ENST00000328118.3
|
FMNL1
|
formin-like 1 |
| chr5_+_133861339 | 2.37 |
ENST00000282605.4
ENST00000361895.2 ENST00000402835.1 |
PHF15
|
jade family PHD finger 2 |
| chr1_-_40367668 | 2.35 |
ENST00000397332.2
ENST00000429311.1 |
MYCL
|
v-myc avian myelocytomatosis viral oncogene lung carcinoma derived homolog |
| chr19_-_10679697 | 2.32 |
ENST00000335766.2
|
CDKN2D
|
cyclin-dependent kinase inhibitor 2D (p19, inhibits CDK4) |
| chr1_-_200992827 | 2.29 |
ENST00000332129.2
ENST00000422435.2 |
KIF21B
|
kinesin family member 21B |
| chr19_+_16435625 | 2.27 |
ENST00000248071.5
ENST00000592003.1 |
KLF2
|
Kruppel-like factor 2 |
| chr2_-_37551846 | 2.27 |
ENST00000443187.1
|
PRKD3
|
protein kinase D3 |
| chrX_-_153363125 | 2.24 |
ENST00000407218.1
ENST00000453960.2 |
MECP2
|
methyl CpG binding protein 2 (Rett syndrome) |
| chr2_+_219264762 | 2.21 |
ENST00000452977.1
|
CTDSP1
|
CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase 1 |
| chr8_-_37756972 | 2.20 |
ENST00000330843.4
ENST00000522727.1 ENST00000287263.4 |
RAB11FIP1
|
RAB11 family interacting protein 1 (class I) |
| chr6_-_30654977 | 2.19 |
ENST00000399199.3
|
PPP1R18
|
protein phosphatase 1, regulatory subunit 18 |
| chr18_-_48723690 | 2.15 |
ENST00000406189.3
|
MEX3C
|
mex-3 RNA binding family member C |
| chr7_+_129251531 | 2.15 |
ENST00000393232.1
ENST00000353868.4 ENST00000539636.1 ENST00000454688.1 ENST00000223190.4 ENST00000311967.2 |
NRF1
|
nuclear respiratory factor 1 |
| chr4_-_109090106 | 2.15 |
ENST00000379951.2
|
LEF1
|
lymphoid enhancer-binding factor 1 |
| chr3_-_113465065 | 2.14 |
ENST00000497255.1
ENST00000478020.1 ENST00000240922.3 ENST00000493900.1 |
NAA50
|
N(alpha)-acetyltransferase 50, NatE catalytic subunit |
| chr6_-_112194484 | 2.14 |
ENST00000518295.1
ENST00000484067.2 ENST00000229470.5 ENST00000356013.2 ENST00000368678.4 ENST00000523238.1 ENST00000354650.3 |
FYN
|
FYN oncogene related to SRC, FGR, YES |
| chr4_-_174255400 | 2.14 |
ENST00000506267.1
|
HMGB2
|
high mobility group box 2 |
| chr6_+_137243373 | 2.12 |
ENST00000331858.4
|
SLC35D3
|
solute carrier family 35, member D3 |
| chr19_-_14247365 | 2.12 |
ENST00000592798.1
ENST00000474890.1 |
ASF1B
|
anti-silencing function 1B histone chaperone |
| chr5_-_140998616 | 2.10 |
ENST00000389054.3
ENST00000398562.2 ENST00000389057.5 ENST00000398566.3 ENST00000398557.4 ENST00000253811.6 |
DIAPH1
|
diaphanous-related formin 1 |
| chr2_+_232573208 | 2.09 |
ENST00000409115.3
|
PTMA
|
prothymosin, alpha |
| chr6_+_135502466 | 2.04 |
ENST00000367814.4
|
MYB
|
v-myb avian myeloblastosis viral oncogene homolog |
| chr5_+_56111361 | 2.04 |
ENST00000399503.3
|
MAP3K1
|
mitogen-activated protein kinase kinase kinase 1, E3 ubiquitin protein ligase |
| chr5_+_133861790 | 2.03 |
ENST00000395003.1
|
PHF15
|
jade family PHD finger 2 |
| chr1_+_43148059 | 2.02 |
ENST00000321358.7
ENST00000332220.6 |
YBX1
|
Y box binding protein 1 |
| chr15_+_57211318 | 2.01 |
ENST00000557947.1
|
TCF12
|
transcription factor 12 |
| chr5_+_61602236 | 2.01 |
ENST00000514082.1
ENST00000407818.3 |
KIF2A
|
kinesin heavy chain member 2A |
| chr15_-_75743915 | 2.01 |
ENST00000394949.4
|
SIN3A
|
SIN3 transcription regulator family member A |
| chrX_-_46618490 | 2.01 |
ENST00000328306.4
|
SLC9A7
|
solute carrier family 9, subfamily A (NHE7, cation proton antiporter 7), member 7 |
| chr6_+_37137939 | 2.00 |
ENST00000373509.5
|
PIM1
|
pim-1 oncogene |
| chr1_+_110026544 | 2.00 |
ENST00000369870.3
|
ATXN7L2
|
ataxin 7-like 2 |
| chr2_+_149402553 | 2.00 |
ENST00000258484.6
ENST00000409654.1 |
EPC2
|
enhancer of polycomb homolog 2 (Drosophila) |
| chr1_+_100818156 | 2.00 |
ENST00000336454.3
|
CDC14A
|
cell division cycle 14A |
| chr6_+_20403997 | 1.99 |
ENST00000535432.1
|
E2F3
|
E2F transcription factor 3 |
| chr17_-_66287350 | 1.98 |
ENST00000580666.1
ENST00000583477.1 |
SLC16A6
|
solute carrier family 16, member 6 |
| chr3_-_71114066 | 1.98 |
ENST00000485326.2
|
FOXP1
|
forkhead box P1 |
| chr18_-_5296001 | 1.96 |
ENST00000357006.4
|
ZBTB14
|
zinc finger and BTB domain containing 14 |
| chr4_-_18023350 | 1.95 |
ENST00000539056.1
ENST00000382226.5 ENST00000326877.4 |
LCORL
|
ligand dependent nuclear receptor corepressor-like |
| chr16_-_58034357 | 1.95 |
ENST00000562909.1
|
ZNF319
|
zinc finger protein 319 |
| chr1_-_153895377 | 1.94 |
ENST00000368655.4
|
GATAD2B
|
GATA zinc finger domain containing 2B |
| chr3_+_50273625 | 1.93 |
ENST00000536647.1
|
GNAI2
|
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 2 |
| chr2_+_219264466 | 1.93 |
ENST00000273062.2
|
CTDSP1
|
CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase 1 |
| chr17_-_4852243 | 1.93 |
ENST00000225655.5
|
PFN1
|
profilin 1 |
| chr4_-_78740511 | 1.91 |
ENST00000504123.1
ENST00000264903.4 ENST00000515441.1 |
CNOT6L
|
CCR4-NOT transcription complex, subunit 6-like |
| chr11_-_2292182 | 1.90 |
ENST00000331289.4
|
ASCL2
|
achaete-scute family bHLH transcription factor 2 |
| chr17_+_43299156 | 1.90 |
ENST00000331495.3
|
FMNL1
|
formin-like 1 |
| chr6_-_91006627 | 1.90 |
ENST00000537989.1
|
BACH2
|
BTB and CNC homology 1, basic leucine zipper transcription factor 2 |
| chr14_-_91884115 | 1.89 |
ENST00000389857.6
|
CCDC88C
|
coiled-coil domain containing 88C |
| chr3_-_13921594 | 1.87 |
ENST00000285018.4
|
WNT7A
|
wingless-type MMTV integration site family, member 7A |
| chr1_+_26798955 | 1.87 |
ENST00000361427.5
|
HMGN2
|
high mobility group nucleosomal binding domain 2 |
| chr3_+_47021168 | 1.86 |
ENST00000450053.3
ENST00000292309.5 ENST00000383740.2 |
NBEAL2
|
neurobeachin-like 2 |
| chr1_+_206680879 | 1.86 |
ENST00000355294.4
ENST00000367117.3 |
RASSF5
|
Ras association (RalGDS/AF-6) domain family member 5 |
| chr1_-_154155595 | 1.85 |
ENST00000328159.4
ENST00000368531.2 ENST00000323144.7 ENST00000368533.3 ENST00000341372.3 |
TPM3
|
tropomyosin 3 |
| chr14_+_75894714 | 1.82 |
ENST00000559060.1
|
JDP2
|
Jun dimerization protein 2 |
| chr6_+_139456226 | 1.81 |
ENST00000367658.2
|
HECA
|
headcase homolog (Drosophila) |
| chr14_-_99737565 | 1.80 |
ENST00000357195.3
|
BCL11B
|
B-cell CLL/lymphoma 11B (zinc finger protein) |
| chr3_-_52090461 | 1.80 |
ENST00000296483.6
ENST00000495880.1 |
DUSP7
|
dual specificity phosphatase 7 |
| chr14_+_64971292 | 1.78 |
ENST00000358738.3
ENST00000394712.2 |
ZBTB1
|
zinc finger and BTB domain containing 1 |
| chr14_-_64971288 | 1.77 |
ENST00000394715.1
|
ZBTB25
|
zinc finger and BTB domain containing 25 |
| chr20_-_20693131 | 1.77 |
ENST00000202677.7
|
RALGAPA2
|
Ral GTPase activating protein, alpha subunit 2 (catalytic) |
| chr16_+_50776021 | 1.76 |
ENST00000566679.2
ENST00000564634.1 ENST00000398568.2 |
CYLD
|
cylindromatosis (turban tumor syndrome) |
| chr6_-_86352982 | 1.75 |
ENST00000369622.3
|
SYNCRIP
|
synaptotagmin binding, cytoplasmic RNA interacting protein |
| chr9_+_130547958 | 1.75 |
ENST00000421939.1
ENST00000373265.2 |
CDK9
|
cyclin-dependent kinase 9 |
| chr3_+_133292759 | 1.74 |
ENST00000431519.2
|
CDV3
|
CDV3 homolog (mouse) |
| chr5_+_179159813 | 1.73 |
ENST00000292599.3
|
MAML1
|
mastermind-like 1 (Drosophila) |
| chr7_-_5463175 | 1.72 |
ENST00000399537.4
ENST00000430969.1 |
TNRC18
|
trinucleotide repeat containing 18 |
| chr19_+_38810447 | 1.71 |
ENST00000263372.3
|
KCNK6
|
potassium channel, subfamily K, member 6 |
| chr1_-_40367530 | 1.71 |
ENST00000372816.2
ENST00000372815.1 |
MYCL
|
v-myc avian myelocytomatosis viral oncogene lung carcinoma derived homolog |
| chr6_+_108881012 | 1.71 |
ENST00000343882.6
|
FOXO3
|
forkhead box O3 |
| chr15_-_70388943 | 1.70 |
ENST00000559048.1
ENST00000560939.1 ENST00000440567.3 ENST00000557907.1 ENST00000558379.1 ENST00000451782.2 ENST00000559929.1 |
TLE3
|
transducin-like enhancer of split 3 (E(sp1) homolog, Drosophila) |
| chr6_-_151712673 | 1.70 |
ENST00000325144.4
|
ZBTB2
|
zinc finger and BTB domain containing 2 |
| chr12_-_129308041 | 1.69 |
ENST00000376740.4
|
SLC15A4
|
solute carrier family 15 (oligopeptide transporter), member 4 |
| chr2_+_48541776 | 1.69 |
ENST00000413569.1
ENST00000340553.3 |
FOXN2
|
forkhead box N2 |
| chr6_+_41514305 | 1.68 |
ENST00000409208.1
ENST00000373057.3 |
FOXP4
|
forkhead box P4 |
| chr5_+_61602055 | 1.67 |
ENST00000381103.2
|
KIF2A
|
kinesin heavy chain member 2A |
| chr12_-_58240470 | 1.67 |
ENST00000548823.1
ENST00000398073.2 |
CTDSP2
|
CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase 2 |
| chr6_+_34204642 | 1.66 |
ENST00000347617.6
ENST00000401473.3 ENST00000311487.5 ENST00000447654.1 ENST00000395004.3 |
HMGA1
|
high mobility group AT-hook 1 |
| chr10_+_104263743 | 1.66 |
ENST00000369902.3
ENST00000369899.2 ENST00000423559.2 |
SUFU
|
suppressor of fused homolog (Drosophila) |
| chr19_-_47734448 | 1.65 |
ENST00000439096.2
|
BBC3
|
BCL2 binding component 3 |
| chr11_-_62314268 | 1.65 |
ENST00000257247.7
ENST00000531324.1 ENST00000378024.4 |
AHNAK
|
AHNAK nucleoprotein |
| chr7_-_72936608 | 1.64 |
ENST00000404251.1
|
BAZ1B
|
bromodomain adjacent to zinc finger domain, 1B |
| chr17_+_19282064 | 1.64 |
ENST00000603493.1
|
MAPK7
|
mitogen-activated protein kinase 7 |
| chr15_+_44719394 | 1.64 |
ENST00000260327.4
ENST00000396780.1 |
CTDSPL2
|
CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase like 2 |
| chr15_+_40733387 | 1.64 |
ENST00000416165.1
|
BAHD1
|
bromo adjacent homology domain containing 1 |
| chr17_+_30814707 | 1.63 |
ENST00000584792.1
|
CDK5R1
|
cyclin-dependent kinase 5, regulatory subunit 1 (p35) |
| chr1_+_154297988 | 1.63 |
ENST00000368487.3
|
ATP8B2
|
ATPase, aminophospholipid transporter, class I, type 8B, member 2 |
| chr12_+_122064673 | 1.63 |
ENST00000537188.1
|
ORAI1
|
ORAI calcium release-activated calcium modulator 1 |
| chr16_+_50775971 | 1.63 |
ENST00000311559.9
ENST00000564326.1 ENST00000566206.1 |
CYLD
|
cylindromatosis (turban tumor syndrome) |
| chr12_-_54694807 | 1.61 |
ENST00000435572.2
|
NFE2
|
nuclear factor, erythroid 2 |
| chr7_+_2671663 | 1.61 |
ENST00000407643.1
|
TTYH3
|
tweety family member 3 |
| chr17_-_3867585 | 1.61 |
ENST00000359983.3
ENST00000352011.3 ENST00000397043.3 ENST00000397041.3 ENST00000397035.3 ENST00000397039.1 ENST00000309890.7 |
ATP2A3
|
ATPase, Ca++ transporting, ubiquitous |
| chr22_-_36784035 | 1.60 |
ENST00000216181.5
|
MYH9
|
myosin, heavy chain 9, non-muscle |
| chr21_-_36260980 | 1.60 |
ENST00000344691.4
ENST00000358356.5 |
RUNX1
|
runt-related transcription factor 1 |
| chr5_+_176873789 | 1.58 |
ENST00000323249.3
ENST00000502922.1 |
PRR7
|
proline rich 7 (synaptic) |
| chr16_+_50775948 | 1.57 |
ENST00000569681.1
ENST00000569418.1 ENST00000540145.1 |
CYLD
|
cylindromatosis (turban tumor syndrome) |
| chr17_+_57232690 | 1.57 |
ENST00000262293.4
|
PRR11
|
proline rich 11 |
| chr10_+_8096631 | 1.56 |
ENST00000379328.3
|
GATA3
|
GATA binding protein 3 |
| chr12_-_54694758 | 1.56 |
ENST00000553070.1
|
NFE2
|
nuclear factor, erythroid 2 |
| chr2_+_219081817 | 1.56 |
ENST00000315717.5
ENST00000420104.1 ENST00000295685.10 |
ARPC2
|
actin related protein 2/3 complex, subunit 2, 34kDa |
| chr19_+_18530184 | 1.55 |
ENST00000601357.2
|
SSBP4
|
single stranded DNA binding protein 4 |
| chr9_-_123476612 | 1.55 |
ENST00000426959.1
|
MEGF9
|
multiple EGF-like-domains 9 |
| chr19_+_18530146 | 1.55 |
ENST00000348495.6
ENST00000270061.7 |
SSBP4
|
single stranded DNA binding protein 4 |
| chr2_+_232573222 | 1.54 |
ENST00000341369.7
ENST00000409683.1 |
PTMA
|
prothymosin, alpha |
| chr5_-_140998481 | 1.54 |
ENST00000518047.1
|
DIAPH1
|
diaphanous-related formin 1 |
| chr6_+_135502408 | 1.53 |
ENST00000341911.5
ENST00000442647.2 ENST00000316528.8 |
MYB
|
v-myb avian myeloblastosis viral oncogene homolog |
| chr19_-_41859814 | 1.52 |
ENST00000221930.5
|
TGFB1
|
transforming growth factor, beta 1 |
| chr17_+_66287628 | 1.51 |
ENST00000581639.1
ENST00000452479.2 |
ARSG
|
arylsulfatase G |
| chr17_-_42296855 | 1.50 |
ENST00000436088.1
|
UBTF
|
upstream binding transcription factor, RNA polymerase I |
| chr15_-_73075964 | 1.50 |
ENST00000563907.1
|
ADPGK
|
ADP-dependent glucokinase |
| chr1_-_92351666 | 1.50 |
ENST00000465892.2
ENST00000417833.2 |
TGFBR3
|
transforming growth factor, beta receptor III |
| chrX_-_20284958 | 1.50 |
ENST00000379565.3
|
RPS6KA3
|
ribosomal protein S6 kinase, 90kDa, polypeptide 3 |
| chr12_+_53846594 | 1.50 |
ENST00000550192.1
|
PCBP2
|
poly(rC) binding protein 2 |
| chr1_-_183604794 | 1.49 |
ENST00000367534.1
ENST00000359856.6 ENST00000294742.6 |
ARPC5
|
actin related protein 2/3 complex, subunit 5, 16kDa |
| chr5_+_133859996 | 1.49 |
ENST00000512386.1
|
PHF15
|
jade family PHD finger 2 |
| chr1_+_118148556 | 1.49 |
ENST00000369448.3
|
FAM46C
|
family with sequence similarity 46, member C |
| chr19_-_14117074 | 1.49 |
ENST00000588885.1
ENST00000254325.4 |
RFX1
|
regulatory factor X, 1 (influences HLA class II expression) |
| chr20_-_31172598 | 1.48 |
ENST00000201961.2
|
C20orf112
|
chromosome 20 open reading frame 112 |
| chr12_+_122241928 | 1.48 |
ENST00000604567.1
ENST00000542440.1 |
SETD1B
|
SET domain containing 1B |
| chr2_+_97481974 | 1.48 |
ENST00000377060.3
ENST00000305510.3 |
CNNM3
|
cyclin M3 |
| chr17_-_16395455 | 1.48 |
ENST00000409083.3
|
FAM211A
|
family with sequence similarity 211, member A |
| chr17_-_46507537 | 1.48 |
ENST00000336915.6
|
SKAP1
|
src kinase associated phosphoprotein 1 |
| chr7_+_98972327 | 1.47 |
ENST00000455009.1
|
ARPC1B
|
actin related protein 2/3 complex, subunit 1B, 41kDa |
| chr19_+_17666403 | 1.47 |
ENST00000252599.4
|
COLGALT1
|
collagen beta(1-O)galactosyltransferase 1 |
| chr10_+_8096769 | 1.47 |
ENST00000346208.3
|
GATA3
|
GATA binding protein 3 |
| chr17_+_34901353 | 1.47 |
ENST00000593016.1
|
GGNBP2
|
gametogenetin binding protein 2 |
| chr14_+_64971438 | 1.47 |
ENST00000555321.1
|
ZBTB1
|
zinc finger and BTB domain containing 1 |
| chr7_+_39989946 | 1.47 |
ENST00000340829.5
|
CDK13
|
cyclin-dependent kinase 13 |
| chr17_-_38574169 | 1.47 |
ENST00000423485.1
|
TOP2A
|
topoisomerase (DNA) II alpha 170kDa |
| chr3_+_14444063 | 1.46 |
ENST00000454876.2
ENST00000360861.3 ENST00000416216.2 |
SLC6A6
|
solute carrier family 6 (neurotransmitter transporter), member 6 |
| chr1_+_26856236 | 1.46 |
ENST00000374168.2
ENST00000374166.4 |
RPS6KA1
|
ribosomal protein S6 kinase, 90kDa, polypeptide 1 |
| chr10_+_105253661 | 1.46 |
ENST00000369780.4
|
NEURL
|
neuralized E3 ubiquitin protein ligase 1 |
| chr11_-_129872672 | 1.46 |
ENST00000531431.1
ENST00000527581.1 |
PRDM10
|
PR domain containing 10 |
| chr10_-_106098162 | 1.46 |
ENST00000337478.1
|
ITPRIP
|
inositol 1,4,5-trisphosphate receptor interacting protein |
| chr15_+_75074410 | 1.45 |
ENST00000439220.2
|
CSK
|
c-src tyrosine kinase |
| chr10_+_75757863 | 1.45 |
ENST00000372755.3
ENST00000211998.4 ENST00000417648.2 |
VCL
|
vinculin |
| chr5_+_61601965 | 1.45 |
ENST00000401507.3
|
KIF2A
|
kinesin heavy chain member 2A |
| chr17_-_47865948 | 1.44 |
ENST00000513602.1
|
FAM117A
|
family with sequence similarity 117, member A |
| chr19_+_16222439 | 1.44 |
ENST00000300935.3
|
RAB8A
|
RAB8A, member RAS oncogene family |
| chr14_+_50359773 | 1.44 |
ENST00000298316.5
|
ARF6
|
ADP-ribosylation factor 6 |
| chr1_+_32716857 | 1.44 |
ENST00000482949.1
ENST00000495610.2 |
LCK
|
lymphocyte-specific protein tyrosine kinase |
| chr7_+_50344289 | 1.44 |
ENST00000413698.1
ENST00000359197.5 ENST00000331340.3 ENST00000357364.4 ENST00000343574.5 ENST00000349824.4 ENST00000346667.4 ENST00000440768.2 |
IKZF1
|
IKAROS family zinc finger 1 (Ikaros) |
| chr7_+_98972298 | 1.44 |
ENST00000252725.5
|
ARPC1B
|
actin related protein 2/3 complex, subunit 1B, 41kDa |
| chr17_-_28257080 | 1.44 |
ENST00000579954.1
ENST00000540801.1 ENST00000269033.3 ENST00000590153.1 ENST00000582084.1 |
SSH2
|
slingshot protein phosphatase 2 |
| chr6_+_31540056 | 1.44 |
ENST00000418386.2
|
LTA
|
lymphotoxin alpha |
| chr7_+_143078379 | 1.43 |
ENST00000449630.1
ENST00000457235.1 |
ZYX
|
zyxin |
| chr11_+_67033881 | 1.42 |
ENST00000308595.5
ENST00000526285.1 |
ADRBK1
|
adrenergic, beta, receptor kinase 1 |
| chr9_-_115095851 | 1.42 |
ENST00000343327.2
|
PTBP3
|
polypyrimidine tract binding protein 3 |
| chr15_+_75074385 | 1.42 |
ENST00000220003.9
|
CSK
|
c-src tyrosine kinase |
| chr1_+_32716840 | 1.41 |
ENST00000336890.5
|
LCK
|
lymphocyte-specific protein tyrosine kinase |
| chr11_-_64511789 | 1.41 |
ENST00000419843.1
ENST00000394430.1 |
RASGRP2
|
RAS guanyl releasing protein 2 (calcium and DAG-regulated) |
| chr4_+_129732419 | 1.41 |
ENST00000510308.1
|
PHF17
|
jade family PHD finger 1 |
| chr8_-_66754172 | 1.41 |
ENST00000401827.3
|
PDE7A
|
phosphodiesterase 7A |
| chr4_-_78740769 | 1.41 |
ENST00000512485.1
|
CNOT6L
|
CCR4-NOT transcription complex, subunit 6-like |
| chr6_-_86353510 | 1.40 |
ENST00000444272.1
|
SYNCRIP
|
synaptotagmin binding, cytoplasmic RNA interacting protein |
| chr16_-_67281413 | 1.40 |
ENST00000258201.4
|
FHOD1
|
formin homology 2 domain containing 1 |
| chr18_-_5296138 | 1.40 |
ENST00000400143.3
|
ZBTB14
|
zinc finger and BTB domain containing 14 |
| chr12_-_1703331 | 1.40 |
ENST00000339235.3
|
FBXL14
|
F-box and leucine-rich repeat protein 14 |
| chr9_-_115095883 | 1.39 |
ENST00000450374.1
ENST00000374255.2 ENST00000334318.6 ENST00000374257.1 |
PTBP3
|
polypyrimidine tract binding protein 3 |
| chr7_+_143078652 | 1.39 |
ENST00000354434.4
ENST00000449423.2 |
ZYX
|
zyxin |
| chr17_-_47308128 | 1.38 |
ENST00000413580.1
ENST00000511066.1 |
PHOSPHO1
|
phosphatase, orphan 1 |
| chr6_+_32939964 | 1.38 |
ENST00000607833.1
|
BRD2
|
bromodomain containing 2 |
| chr18_+_3449821 | 1.37 |
ENST00000407501.2
ENST00000405385.3 ENST00000546979.1 |
TGIF1
|
TGFB-induced factor homeobox 1 |
| chr16_-_4323015 | 1.36 |
ENST00000204517.6
|
TFAP4
|
transcription factor AP-4 (activating enhancer binding protein 4) |
Network of associatons between targets according to the STRING database.
First level regulatory network of TFDP1
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.4 | 7.1 | GO:1990922 | regulation of hepatic stellate cell proliferation(GO:1904897) positive regulation of hepatic stellate cell proliferation(GO:1904899) hepatic stellate cell proliferation(GO:1990922) |
| 1.8 | 12.5 | GO:0048619 | embryonic genitalia morphogenesis(GO:0030538) embryonic hindgut morphogenesis(GO:0048619) |
| 1.7 | 5.0 | GO:1990108 | protein linear deubiquitination(GO:1990108) |
| 1.4 | 4.3 | GO:0097534 | lymphoid lineage cell migration(GO:0097534) lymphoid lineage cell migration into thymus(GO:0097535) |
| 1.4 | 8.3 | GO:0002572 | pro-T cell differentiation(GO:0002572) |
| 1.2 | 5.9 | GO:0071409 | cellular response to cycloheximide(GO:0071409) |
| 1.1 | 1.1 | GO:1901674 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
| 1.1 | 13.2 | GO:0001866 | NK T cell proliferation(GO:0001866) |
| 1.0 | 3.1 | GO:0009405 | pathogenesis(GO:0009405) |
| 1.0 | 7.1 | GO:0003408 | optic cup formation involved in camera-type eye development(GO:0003408) maintenance of chromatin silencing(GO:0006344) |
| 1.0 | 2.0 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
| 0.9 | 10.4 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
| 0.9 | 0.9 | GO:0009617 | response to bacterium(GO:0009617) |
| 0.8 | 0.8 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
| 0.8 | 4.1 | GO:0044027 | hypermethylation of CpG island(GO:0044027) |
| 0.8 | 3.2 | GO:1904799 | regulation of neuron remodeling(GO:1904799) negative regulation of neuron remodeling(GO:1904800) negative regulation of branching morphogenesis of a nerve(GO:2000173) |
| 0.8 | 2.3 | GO:0048210 | Golgi vesicle fusion to target membrane(GO:0048210) |
| 0.8 | 2.3 | GO:0070376 | regulation of ERK5 cascade(GO:0070376) negative regulation of ERK5 cascade(GO:0070377) |
| 0.7 | 2.2 | GO:0033037 | polysaccharide localization(GO:0033037) |
| 0.7 | 3.6 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
| 0.7 | 3.5 | GO:1901675 | negative regulation of histone H3-K27 acetylation(GO:1901675) |
| 0.7 | 5.6 | GO:2000980 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
| 0.7 | 8.2 | GO:0003223 | ventricular compact myocardium morphogenesis(GO:0003223) |
| 0.6 | 2.6 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
| 0.6 | 0.6 | GO:1901655 | cellular response to ketone(GO:1901655) |
| 0.6 | 4.3 | GO:1904688 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
| 0.6 | 0.6 | GO:0034770 | histone H4-K20 methylation(GO:0034770) histone H4-K20 trimethylation(GO:0034773) |
| 0.6 | 2.4 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
| 0.6 | 1.8 | GO:0006117 | acetaldehyde metabolic process(GO:0006117) |
| 0.6 | 1.8 | GO:1902396 | protein localization to bicellular tight junction(GO:1902396) |
| 0.6 | 1.8 | GO:0021775 | smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
| 0.6 | 1.7 | GO:0001544 | initiation of primordial ovarian follicle growth(GO:0001544) |
| 0.6 | 0.6 | GO:0014029 | neural crest formation(GO:0014029) |
| 0.6 | 0.6 | GO:0050653 | chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0050653) |
| 0.5 | 1.6 | GO:0021722 | superior olivary nucleus development(GO:0021718) superior olivary nucleus maturation(GO:0021722) |
| 0.5 | 2.6 | GO:0002032 | desensitization of G-protein coupled receptor protein signaling pathway by arrestin(GO:0002032) |
| 0.5 | 1.6 | GO:0072387 | flavin adenine dinucleotide metabolic process(GO:0072387) |
| 0.5 | 2.6 | GO:0003430 | growth plate cartilage chondrocyte growth(GO:0003430) |
| 0.5 | 1.5 | GO:0044416 | induction by symbiont of host defense response(GO:0044416) induction of host immune response by virus(GO:0046730) active induction of host immune response by virus(GO:0046732) modulation by symbiont of host defense response(GO:0052031) induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) modulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052255) positive regulation by symbiont of host defense response(GO:0052509) positive regulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052510) modulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052552) modulation by symbiont of host immune response(GO:0052553) modulation by virus of host immune response(GO:0075528) |
| 0.5 | 1.9 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
| 0.5 | 1.4 | GO:0002874 | regulation of chronic inflammatory response to antigenic stimulus(GO:0002874) |
| 0.5 | 1.4 | GO:1904247 | positive regulation of polynucleotide adenylyltransferase activity(GO:1904247) |
| 0.5 | 2.3 | GO:1904868 | telomerase catalytic core complex assembly(GO:1904868) regulation of telomerase catalytic core complex assembly(GO:1904882) positive regulation of telomerase catalytic core complex assembly(GO:1904884) |
| 0.5 | 0.9 | GO:0035407 | histone H3-T11 phosphorylation(GO:0035407) |
| 0.5 | 2.3 | GO:1900224 | positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) |
| 0.5 | 1.4 | GO:0017186 | peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase(GO:0017186) |
| 0.5 | 1.8 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
| 0.5 | 1.8 | GO:0010909 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition(GO:0044334) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
| 0.5 | 1.8 | GO:0000415 | negative regulation of histone H3-K36 methylation(GO:0000415) |
| 0.5 | 5.4 | GO:0048102 | autophagic cell death(GO:0048102) |
| 0.5 | 1.8 | GO:0002268 | follicular dendritic cell differentiation(GO:0002268) |
| 0.4 | 1.3 | GO:0044727 | DNA demethylation of male pronucleus(GO:0044727) |
| 0.4 | 5.8 | GO:1902659 | regulation of glucose mediated signaling pathway(GO:1902659) |
| 0.4 | 0.9 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
| 0.4 | 2.2 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
| 0.4 | 1.3 | GO:1903461 | Okazaki fragment processing involved in mitotic DNA replication(GO:1903461) |
| 0.4 | 1.7 | GO:0033140 | negative regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033140) |
| 0.4 | 6.4 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
| 0.4 | 1.3 | GO:1902823 | negative regulation of late endosome to lysosome transport(GO:1902823) |
| 0.4 | 0.4 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
| 0.4 | 4.6 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
| 0.4 | 1.2 | GO:0045083 | negative regulation of interleukin-12 biosynthetic process(GO:0045083) |
| 0.4 | 2.8 | GO:0022614 | membrane to membrane docking(GO:0022614) |
| 0.4 | 3.6 | GO:1902748 | positive regulation of lens fiber cell differentiation(GO:1902748) |
| 0.4 | 1.2 | GO:1905000 | regulation of membrane repolarization during atrial cardiac muscle cell action potential(GO:1905000) |
| 0.4 | 5.5 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
| 0.4 | 0.8 | GO:0061145 | bronchus cartilage development(GO:0060532) lung smooth muscle development(GO:0061145) |
| 0.4 | 3.1 | GO:0021861 | forebrain radial glial cell differentiation(GO:0021861) |
| 0.4 | 0.4 | GO:2000777 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia(GO:2000777) |
| 0.4 | 5.3 | GO:0007144 | female meiosis I(GO:0007144) |
| 0.4 | 3.0 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
| 0.4 | 0.4 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
| 0.4 | 1.5 | GO:0036071 | N-glycan fucosylation(GO:0036071) |
| 0.4 | 1.1 | GO:1904772 | hepatocyte homeostasis(GO:0036333) response to tetrachloromethane(GO:1904772) |
| 0.4 | 2.2 | GO:1903438 | regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
| 0.4 | 1.4 | GO:0032072 | plasmacytoid dendritic cell activation(GO:0002270) regulation of restriction endodeoxyribonuclease activity(GO:0032072) |
| 0.4 | 1.1 | GO:0021571 | rhombomere 5 development(GO:0021571) central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
| 0.4 | 1.4 | GO:1903028 | positive regulation of opsonization(GO:1903028) |
| 0.4 | 1.8 | GO:0090402 | oncogene-induced cell senescence(GO:0090402) |
| 0.4 | 1.1 | GO:0034471 | endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000472) rRNA 5'-end processing(GO:0000967) ncRNA 5'-end processing(GO:0034471) |
| 0.4 | 1.1 | GO:0000349 | generation of catalytic spliceosome for first transesterification step(GO:0000349) |
| 0.3 | 2.1 | GO:0021993 | initiation of neural tube closure(GO:0021993) |
| 0.3 | 1.0 | GO:1903450 | regulation of G1 to G0 transition(GO:1903450) positive regulation of G1 to G0 transition(GO:1903452) |
| 0.3 | 1.0 | GO:2000681 | negative regulation of rubidium ion transport(GO:2000681) negative regulation of rubidium ion transmembrane transporter activity(GO:2000687) |
| 0.3 | 3.7 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.3 | 0.3 | GO:1990791 | dorsal root ganglion development(GO:1990791) |
| 0.3 | 1.3 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
| 0.3 | 1.7 | GO:0036496 | regulation of translational initiation by eIF2 alpha dephosphorylation(GO:0036496) |
| 0.3 | 1.3 | GO:0015772 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 0.3 | 2.0 | GO:0032625 | interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
| 0.3 | 1.0 | GO:1903519 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
| 0.3 | 4.5 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
| 0.3 | 0.3 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
| 0.3 | 1.6 | GO:0032796 | uropod organization(GO:0032796) |
| 0.3 | 1.0 | GO:0061110 | dense core granule biogenesis(GO:0061110) regulation of dense core granule biogenesis(GO:2000705) |
| 0.3 | 1.6 | GO:1905167 | positive regulation of lysosomal protein catabolic process(GO:1905167) |
| 0.3 | 1.9 | GO:0071386 | cellular response to corticosterone stimulus(GO:0071386) |
| 0.3 | 1.2 | GO:0060374 | mast cell differentiation(GO:0060374) |
| 0.3 | 2.2 | GO:0070417 | cellular response to cold(GO:0070417) |
| 0.3 | 1.5 | GO:0043987 | histone H3-S10 phosphorylation(GO:0043987) |
| 0.3 | 1.2 | GO:0060623 | pericentric heterochromatin assembly(GO:0031508) regulation of chromosome condensation(GO:0060623) |
| 0.3 | 1.5 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
| 0.3 | 1.5 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
| 0.3 | 1.5 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
| 0.3 | 5.5 | GO:0051256 | mitotic spindle midzone assembly(GO:0051256) |
| 0.3 | 0.6 | GO:0060435 | bronchiole development(GO:0060435) |
| 0.3 | 4.9 | GO:0051573 | negative regulation of histone H3-K9 methylation(GO:0051573) |
| 0.3 | 2.9 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
| 0.3 | 4.0 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
| 0.3 | 0.6 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
| 0.3 | 1.1 | GO:0097010 | eukaryotic translation initiation factor 4F complex assembly(GO:0097010) |
| 0.3 | 6.9 | GO:0006337 | nucleosome disassembly(GO:0006337) |
| 0.3 | 1.1 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
| 0.3 | 0.5 | GO:0001172 | transcription, RNA-templated(GO:0001172) |
| 0.3 | 0.8 | GO:0072356 | chromosome passenger complex localization to kinetochore(GO:0072356) |
| 0.3 | 2.7 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
| 0.3 | 4.0 | GO:0035372 | protein localization to microtubule(GO:0035372) |
| 0.3 | 0.5 | GO:0098727 | maintenance of cell number(GO:0098727) |
| 0.3 | 3.4 | GO:0031507 | heterochromatin assembly(GO:0031507) |
| 0.3 | 1.0 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
| 0.3 | 1.8 | GO:0034670 | chemotaxis to arachidonic acid(GO:0034670) response to arachidonic acid(GO:1904550) |
| 0.3 | 2.6 | GO:2001166 | regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
| 0.3 | 0.8 | GO:1901340 | negative regulation of store-operated calcium channel activity(GO:1901340) |
| 0.3 | 9.3 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
| 0.3 | 0.8 | GO:0044205 | 'de novo' UMP biosynthetic process(GO:0044205) |
| 0.3 | 0.8 | GO:1990828 | response to putrescine(GO:1904585) cellular response to putrescine(GO:1904586) hepatocyte dedifferentiation(GO:1990828) |
| 0.3 | 0.5 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
| 0.3 | 3.0 | GO:0006857 | oligopeptide transport(GO:0006857) |
| 0.2 | 0.5 | GO:2000304 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
| 0.2 | 1.7 | GO:0090625 | mRNA cleavage involved in gene silencing by siRNA(GO:0090625) |
| 0.2 | 1.2 | GO:0031291 | Ran protein signal transduction(GO:0031291) |
| 0.2 | 0.5 | GO:0006258 | UDP-glucose catabolic process(GO:0006258) |
| 0.2 | 2.2 | GO:0009048 | dosage compensation by inactivation of X chromosome(GO:0009048) |
| 0.2 | 1.2 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
| 0.2 | 7.1 | GO:0043555 | regulation of translation in response to stress(GO:0043555) |
| 0.2 | 1.7 | GO:0060295 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
| 0.2 | 1.9 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
| 0.2 | 0.5 | GO:0019230 | proprioception(GO:0019230) |
| 0.2 | 0.7 | GO:0042270 | antigen processing and presentation of endogenous peptide antigen via MHC class Ib(GO:0002476) protection from natural killer cell mediated cytotoxicity(GO:0042270) |
| 0.2 | 1.9 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
| 0.2 | 2.4 | GO:0010587 | miRNA catabolic process(GO:0010587) |
| 0.2 | 3.8 | GO:0021702 | cerebellar Purkinje cell layer formation(GO:0021694) cerebellar Purkinje cell differentiation(GO:0021702) |
| 0.2 | 0.5 | GO:1900369 | negative regulation of RNA interference(GO:1900369) |
| 0.2 | 0.9 | GO:0048733 | sebaceous gland development(GO:0048733) |
| 0.2 | 2.3 | GO:0033183 | negative regulation of histone ubiquitination(GO:0033183) regulation of histone H2A K63-linked ubiquitination(GO:1901314) negative regulation of histone H2A K63-linked ubiquitination(GO:1901315) |
| 0.2 | 0.7 | GO:0045081 | negative regulation of interleukin-10 biosynthetic process(GO:0045081) |
| 0.2 | 1.4 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
| 0.2 | 2.3 | GO:0002943 | tRNA dihydrouridine synthesis(GO:0002943) |
| 0.2 | 0.7 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
| 0.2 | 4.3 | GO:0051014 | actin filament severing(GO:0051014) |
| 0.2 | 1.6 | GO:0008063 | Toll signaling pathway(GO:0008063) |
| 0.2 | 0.7 | GO:0060381 | regulation of single-stranded telomeric DNA binding(GO:0060380) positive regulation of single-stranded telomeric DNA binding(GO:0060381) |
| 0.2 | 2.0 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
| 0.2 | 0.7 | GO:0060988 | lipid tube assembly(GO:0060988) |
| 0.2 | 0.7 | GO:0006679 | glucosylceramide biosynthetic process(GO:0006679) |
| 0.2 | 0.9 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
| 0.2 | 2.7 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
| 0.2 | 3.1 | GO:1902951 | negative regulation of dendritic spine maintenance(GO:1902951) |
| 0.2 | 2.4 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
| 0.2 | 2.8 | GO:0060022 | hard palate development(GO:0060022) |
| 0.2 | 0.6 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
| 0.2 | 3.2 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
| 0.2 | 1.5 | GO:0036089 | cleavage furrow formation(GO:0036089) |
| 0.2 | 0.6 | GO:0000961 | negative regulation of mitochondrial RNA catabolic process(GO:0000961) |
| 0.2 | 0.2 | GO:0015813 | acidic amino acid transport(GO:0015800) L-glutamate transport(GO:0015813) |
| 0.2 | 2.3 | GO:0070561 | vitamin D receptor signaling pathway(GO:0070561) |
| 0.2 | 0.6 | GO:0045643 | regulation of eosinophil differentiation(GO:0045643) positive regulation of eosinophil differentiation(GO:0045645) |
| 0.2 | 0.2 | GO:1904975 | response to bleomycin(GO:1904975) cellular response to bleomycin(GO:1904976) |
| 0.2 | 1.5 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
| 0.2 | 1.7 | GO:0007296 | vitellogenesis(GO:0007296) |
| 0.2 | 0.8 | GO:0036292 | DNA rewinding(GO:0036292) |
| 0.2 | 0.6 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
| 0.2 | 1.0 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
| 0.2 | 2.3 | GO:0032264 | IMP salvage(GO:0032264) |
| 0.2 | 0.6 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
| 0.2 | 1.2 | GO:0035900 | response to isolation stress(GO:0035900) |
| 0.2 | 1.2 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
| 0.2 | 1.2 | GO:0030035 | microspike assembly(GO:0030035) |
| 0.2 | 2.8 | GO:0043249 | erythrocyte maturation(GO:0043249) |
| 0.2 | 0.4 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
| 0.2 | 7.6 | GO:0030033 | microvillus assembly(GO:0030033) |
| 0.2 | 1.6 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
| 0.2 | 1.2 | GO:0044782 | cilium organization(GO:0044782) |
| 0.2 | 0.8 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 0.2 | 0.6 | GO:1901860 | positive regulation of mitochondrial DNA metabolic process(GO:1901860) |
| 0.2 | 1.0 | GO:0042631 | cellular response to water deprivation(GO:0042631) |
| 0.2 | 0.4 | GO:0014855 | striated muscle cell proliferation(GO:0014855) |
| 0.2 | 1.3 | GO:0010825 | positive regulation of centrosome duplication(GO:0010825) |
| 0.2 | 1.3 | GO:0033484 | nitric oxide homeostasis(GO:0033484) |
| 0.2 | 0.6 | GO:0098507 | polynucleotide 5' dephosphorylation(GO:0098507) |
| 0.2 | 0.6 | GO:0048250 | mitochondrial iron ion transport(GO:0048250) |
| 0.2 | 0.6 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
| 0.2 | 4.6 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
| 0.2 | 8.2 | GO:1904837 | beta-catenin-TCF complex assembly(GO:1904837) |
| 0.2 | 0.8 | GO:0006272 | leading strand elongation(GO:0006272) |
| 0.2 | 2.1 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
| 0.2 | 3.9 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
| 0.2 | 1.6 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
| 0.2 | 1.6 | GO:0089700 | protein kinase D signaling(GO:0089700) |
| 0.2 | 2.7 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
| 0.2 | 2.9 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
| 0.2 | 0.7 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
| 0.2 | 2.1 | GO:0090481 | pyrimidine nucleotide-sugar transmembrane transport(GO:0090481) |
| 0.2 | 0.5 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
| 0.2 | 1.4 | GO:0098535 | de novo centriole assembly(GO:0098535) |
| 0.2 | 2.3 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
| 0.2 | 0.2 | GO:1990785 | response to water-immersion restraint stress(GO:1990785) |
| 0.2 | 0.7 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
| 0.2 | 0.5 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
| 0.2 | 1.0 | GO:0007386 | compartment pattern specification(GO:0007386) |
| 0.2 | 1.7 | GO:0051013 | microtubule severing(GO:0051013) |
| 0.2 | 3.2 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
| 0.2 | 1.3 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
| 0.2 | 0.5 | GO:0023016 | signal transduction by trans-phosphorylation(GO:0023016) |
| 0.2 | 7.3 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
| 0.2 | 0.6 | GO:0035522 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
| 0.2 | 1.6 | GO:2001300 | lipoxin metabolic process(GO:2001300) |
| 0.2 | 0.8 | GO:0010157 | response to chlorate(GO:0010157) |
| 0.2 | 1.1 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
| 0.2 | 0.5 | GO:0019858 | cytosine metabolic process(GO:0019858) |
| 0.2 | 0.2 | GO:0070858 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
| 0.2 | 0.6 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) |
| 0.2 | 1.1 | GO:0006543 | glutamine catabolic process(GO:0006543) |
| 0.2 | 0.8 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
| 0.2 | 0.5 | GO:1904504 | sphinganine metabolic process(GO:0006667) regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
| 0.1 | 1.0 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
| 0.1 | 0.9 | GO:0030037 | actin filament reorganization involved in cell cycle(GO:0030037) |
| 0.1 | 3.0 | GO:0031065 | positive regulation of histone deacetylation(GO:0031065) |
| 0.1 | 0.6 | GO:0033567 | DNA replication, Okazaki fragment processing(GO:0033567) |
| 0.1 | 2.1 | GO:0002115 | store-operated calcium entry(GO:0002115) |
| 0.1 | 0.6 | GO:0046462 | monoacylglycerol metabolic process(GO:0046462) monoacylglycerol catabolic process(GO:0052651) |
| 0.1 | 0.7 | GO:2001076 | regulation of metanephric ureteric bud development(GO:2001074) positive regulation of metanephric ureteric bud development(GO:2001076) |
| 0.1 | 0.7 | GO:0046543 | development of secondary sexual characteristics(GO:0045136) development of secondary female sexual characteristics(GO:0046543) |
| 0.1 | 0.6 | GO:0002296 | T-helper 1 cell lineage commitment(GO:0002296) |
| 0.1 | 0.4 | GO:1904875 | regulation of DNA ligase activity(GO:1904875) |
| 0.1 | 0.4 | GO:0035621 | ER to Golgi ceramide transport(GO:0035621) |
| 0.1 | 1.7 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
| 0.1 | 0.4 | GO:0040040 | thermosensory behavior(GO:0040040) |
| 0.1 | 0.3 | GO:0098917 | retrograde trans-synaptic signaling(GO:0098917) |
| 0.1 | 3.3 | GO:0038092 | nodal signaling pathway(GO:0038092) |
| 0.1 | 1.1 | GO:0075713 | establishment of integrated proviral latency(GO:0075713) |
| 0.1 | 1.3 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
| 0.1 | 6.7 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
| 0.1 | 0.7 | GO:0003068 | age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
| 0.1 | 1.4 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
| 0.1 | 0.4 | GO:1904924 | negative regulation of mitophagy in response to mitochondrial depolarization(GO:1904924) |
| 0.1 | 1.1 | GO:0002328 | pro-B cell differentiation(GO:0002328) |
| 0.1 | 0.3 | GO:1905051 | regulation of base-excision repair(GO:1905051) positive regulation of base-excision repair(GO:1905053) |
| 0.1 | 1.4 | GO:0018095 | protein polyglutamylation(GO:0018095) |
| 0.1 | 1.2 | GO:0006336 | DNA replication-independent nucleosome assembly(GO:0006336) |
| 0.1 | 1.9 | GO:0070070 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
| 0.1 | 3.2 | GO:0006266 | DNA ligation(GO:0006266) |
| 0.1 | 0.8 | GO:0060968 | regulation of gene silencing(GO:0060968) |
| 0.1 | 0.3 | GO:0046778 | modification by virus of host mRNA processing(GO:0046778) |
| 0.1 | 0.6 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
| 0.1 | 1.4 | GO:0035583 | sequestering of TGFbeta in extracellular matrix(GO:0035583) |
| 0.1 | 0.7 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
| 0.1 | 2.5 | GO:0070914 | UV-damage excision repair(GO:0070914) |
| 0.1 | 0.7 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
| 0.1 | 0.4 | GO:1903936 | response to sodium arsenite(GO:1903935) cellular response to sodium arsenite(GO:1903936) |
| 0.1 | 0.7 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
| 0.1 | 0.2 | GO:0048385 | regulation of retinoic acid receptor signaling pathway(GO:0048385) negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
| 0.1 | 1.6 | GO:1902961 | positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902961) positive regulation of aspartic-type peptidase activity(GO:1905247) |
| 0.1 | 0.8 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
| 0.1 | 4.7 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
| 0.1 | 0.5 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
| 0.1 | 0.7 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
| 0.1 | 0.2 | GO:0080120 | CAAX-box protein processing(GO:0071586) CAAX-box protein maturation(GO:0080120) |
| 0.1 | 0.6 | GO:0090031 | positive regulation of steroid hormone biosynthetic process(GO:0090031) |
| 0.1 | 1.6 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
| 0.1 | 1.0 | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) |
| 0.1 | 0.1 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
| 0.1 | 1.0 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
| 0.1 | 3.5 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
| 0.1 | 2.2 | GO:0035066 | positive regulation of histone acetylation(GO:0035066) positive regulation of peptidyl-lysine acetylation(GO:2000758) |
| 0.1 | 0.5 | GO:0044691 | tooth eruption(GO:0044691) |
| 0.1 | 0.3 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
| 0.1 | 0.8 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 0.1 | 0.4 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
| 0.1 | 0.7 | GO:0061083 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
| 0.1 | 1.4 | GO:2000615 | regulation of histone H3-K9 acetylation(GO:2000615) |
| 0.1 | 0.8 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
| 0.1 | 0.9 | GO:0031061 | negative regulation of histone methylation(GO:0031061) |
| 0.1 | 0.5 | GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) |
| 0.1 | 0.6 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
| 0.1 | 0.4 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
| 0.1 | 3.7 | GO:0030220 | platelet formation(GO:0030220) |
| 0.1 | 1.2 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
| 0.1 | 0.7 | GO:1904896 | ESCRT complex disassembly(GO:1904896) ESCRT III complex disassembly(GO:1904903) |
| 0.1 | 2.9 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
| 0.1 | 2.0 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
| 0.1 | 0.7 | GO:0070375 | ERK5 cascade(GO:0070375) |
| 0.1 | 0.8 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
| 0.1 | 2.0 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
| 0.1 | 0.4 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
| 0.1 | 0.4 | GO:0002913 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
| 0.1 | 0.3 | GO:1901536 | regulation of DNA demethylation(GO:1901535) negative regulation of DNA demethylation(GO:1901536) |
| 0.1 | 0.8 | GO:0043634 | polyadenylation-dependent RNA catabolic process(GO:0043633) polyadenylation-dependent ncRNA catabolic process(GO:0043634) |
| 0.1 | 0.7 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
| 0.1 | 0.9 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
| 0.1 | 1.5 | GO:0018027 | peptidyl-lysine dimethylation(GO:0018027) |
| 0.1 | 1.9 | GO:0030210 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
| 0.1 | 0.3 | GO:0090340 | positive regulation of high-density lipoprotein particle assembly(GO:0090108) positive regulation of secretion of lysosomal enzymes(GO:0090340) |
| 0.1 | 1.8 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
| 0.1 | 1.4 | GO:0006198 | cAMP catabolic process(GO:0006198) |
| 0.1 | 1.5 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
| 0.1 | 1.4 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 0.1 | 0.3 | GO:0032618 | interleukin-15 production(GO:0032618) |
| 0.1 | 2.9 | GO:0045332 | phospholipid translocation(GO:0045332) |
| 0.1 | 1.5 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
| 0.1 | 0.3 | GO:1903926 | signal transduction involved in intra-S DNA damage checkpoint(GO:0072428) negative regulation of mitotic cell cycle DNA replication(GO:1903464) response to bisphenol A(GO:1903925) cellular response to bisphenol A(GO:1903926) |
| 0.1 | 0.1 | GO:0031442 | positive regulation of mRNA 3'-end processing(GO:0031442) |
| 0.1 | 0.4 | GO:1905174 | metanephric glomerular mesangial cell development(GO:0072255) reversible differentiation(GO:0090677) cell dedifferentiation involved in phenotypic switching(GO:0090678) positive regulation of phenotypic switching(GO:1900241) regulation of vascular smooth muscle cell dedifferentiation(GO:1905174) positive regulation of vascular smooth muscle cell dedifferentiation(GO:1905176) vascular smooth muscle cell dedifferentiation(GO:1990936) |
| 0.1 | 0.3 | GO:1903527 | positive regulation of membrane tubulation(GO:1903527) |
| 0.1 | 0.6 | GO:0006116 | NADH oxidation(GO:0006116) |
| 0.1 | 0.7 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
| 0.1 | 2.2 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
| 0.1 | 1.0 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
| 0.1 | 0.6 | GO:0046836 | glycolipid transport(GO:0046836) |
| 0.1 | 1.1 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
| 0.1 | 0.4 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
| 0.1 | 0.5 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
| 0.1 | 1.1 | GO:0045930 | negative regulation of mitotic cell cycle(GO:0045930) |
| 0.1 | 1.7 | GO:0001675 | acrosome assembly(GO:0001675) |
| 0.1 | 1.6 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
| 0.1 | 0.3 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
| 0.1 | 1.5 | GO:0034356 | NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
| 0.1 | 1.0 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
| 0.1 | 0.4 | GO:0010694 | positive regulation of alkaline phosphatase activity(GO:0010694) |
| 0.1 | 0.7 | GO:0090205 | positive regulation of cholesterol metabolic process(GO:0090205) |
| 0.1 | 0.4 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
| 0.1 | 0.8 | GO:0090521 | glomerular visceral epithelial cell migration(GO:0090521) |
| 0.1 | 1.8 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
| 0.1 | 3.2 | GO:0070911 | global genome nucleotide-excision repair(GO:0070911) |
| 0.1 | 1.9 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
| 0.1 | 0.3 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
| 0.1 | 1.4 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
| 0.1 | 0.4 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
| 0.1 | 0.7 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
| 0.1 | 1.2 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
| 0.1 | 1.5 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
| 0.1 | 0.6 | GO:2000035 | regulation of stem cell division(GO:2000035) |
| 0.1 | 0.6 | GO:0045204 | MAPK export from nucleus(GO:0045204) |
| 0.1 | 1.4 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
| 0.1 | 0.7 | GO:0070995 | NADPH oxidation(GO:0070995) |
| 0.1 | 0.6 | GO:0016584 | nucleosome positioning(GO:0016584) |
| 0.1 | 0.4 | GO:0072709 | cellular response to sorbitol(GO:0072709) |
| 0.1 | 1.1 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
| 0.1 | 0.2 | GO:0007518 | myoblast fate determination(GO:0007518) |
| 0.1 | 0.6 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
| 0.1 | 0.4 | GO:0035280 | miRNA loading onto RISC involved in gene silencing by miRNA(GO:0035280) |
| 0.1 | 0.4 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
| 0.1 | 1.4 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
| 0.1 | 0.7 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
| 0.1 | 1.0 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
| 0.1 | 0.6 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
| 0.1 | 1.3 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
| 0.1 | 0.7 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
| 0.1 | 0.9 | GO:0035855 | megakaryocyte development(GO:0035855) |
| 0.1 | 0.8 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
| 0.1 | 1.1 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
| 0.1 | 0.8 | GO:0010993 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
| 0.1 | 1.7 | GO:0032786 | positive regulation of DNA-templated transcription, elongation(GO:0032786) |
| 0.1 | 0.3 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
| 0.1 | 0.4 | GO:1901838 | positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
| 0.1 | 0.4 | GO:0044208 | 'de novo' AMP biosynthetic process(GO:0044208) |
| 0.1 | 0.8 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
| 0.1 | 0.4 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
| 0.1 | 1.9 | GO:1904380 | endoplasmic reticulum mannose trimming(GO:1904380) |
| 0.1 | 1.1 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
| 0.1 | 0.4 | GO:0045669 | positive regulation of osteoblast differentiation(GO:0045669) |
| 0.1 | 0.6 | GO:0010225 | response to UV-C(GO:0010225) |
| 0.1 | 0.1 | GO:1903659 | regulation of complement-dependent cytotoxicity(GO:1903659) |
| 0.1 | 0.6 | GO:0038203 | TORC2 signaling(GO:0038203) |
| 0.1 | 1.5 | GO:0035246 | peptidyl-arginine N-methylation(GO:0035246) |
| 0.1 | 0.3 | GO:1900242 | regulation of synaptic vesicle endocytosis(GO:1900242) |
| 0.1 | 0.2 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
| 0.1 | 1.4 | GO:0036010 | protein localization to endosome(GO:0036010) |
| 0.1 | 2.2 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
| 0.1 | 0.5 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
| 0.1 | 1.4 | GO:0034380 | high-density lipoprotein particle assembly(GO:0034380) |
| 0.1 | 1.2 | GO:0071158 | positive regulation of cell cycle arrest(GO:0071158) |
| 0.1 | 0.5 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.1 | 0.9 | GO:0045046 | protein import into peroxisome membrane(GO:0045046) |
| 0.1 | 0.5 | GO:0043418 | homocysteine catabolic process(GO:0043418) |
| 0.1 | 0.1 | GO:0038030 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
| 0.1 | 0.1 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
| 0.1 | 0.3 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
| 0.1 | 4.8 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
| 0.1 | 0.2 | GO:0098501 | polynucleotide dephosphorylation(GO:0098501) DNA dephosphorylation(GO:0098502) |
| 0.1 | 1.0 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
| 0.1 | 0.6 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
| 0.1 | 0.1 | GO:0021623 | oculomotor nerve morphogenesis(GO:0021622) oculomotor nerve formation(GO:0021623) |
| 0.1 | 4.8 | GO:0090307 | mitotic spindle assembly(GO:0090307) |
| 0.1 | 1.1 | GO:0016246 | RNA interference(GO:0016246) |
| 0.1 | 0.4 | GO:0097150 | neuronal stem cell population maintenance(GO:0097150) |
| 0.1 | 1.3 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
| 0.1 | 0.1 | GO:0017055 | negative regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0017055) |
| 0.1 | 0.2 | GO:0033385 | geranylgeranyl diphosphate metabolic process(GO:0033385) geranylgeranyl diphosphate biosynthetic process(GO:0033386) |
| 0.1 | 3.5 | GO:0060976 | coronary vasculature development(GO:0060976) |
| 0.1 | 0.5 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 0.1 | 0.3 | GO:0046833 | positive regulation of nucleobase-containing compound transport(GO:0032241) positive regulation of RNA export from nucleus(GO:0046833) |
| 0.1 | 0.3 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
| 0.1 | 0.7 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
| 0.1 | 0.5 | GO:0023035 | CD40 signaling pathway(GO:0023035) |
| 0.1 | 0.3 | GO:0009609 | response to symbiont(GO:0009608) response to symbiotic bacterium(GO:0009609) |
| 0.1 | 1.3 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
| 0.1 | 0.2 | GO:0030047 | actin modification(GO:0030047) |
| 0.1 | 0.2 | GO:0016260 | selenocysteine biosynthetic process(GO:0016260) |
| 0.1 | 0.2 | GO:1904046 | negative regulation of vascular endothelial growth factor production(GO:1904046) |
| 0.1 | 0.6 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
| 0.1 | 0.5 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
| 0.1 | 0.3 | GO:0043686 | co-translational protein modification(GO:0043686) |
| 0.1 | 0.9 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
| 0.1 | 0.8 | GO:0010666 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
| 0.1 | 0.2 | GO:0042144 | vacuole fusion, non-autophagic(GO:0042144) |
| 0.1 | 1.6 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
| 0.1 | 0.2 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
| 0.1 | 1.5 | GO:0006465 | signal peptide processing(GO:0006465) |
| 0.1 | 0.5 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 0.1 | 0.6 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
| 0.1 | 0.2 | GO:0016598 | protein arginylation(GO:0016598) |
| 0.1 | 0.2 | GO:0043105 | regulation of GTP cyclohydrolase I activity(GO:0043095) negative regulation of GTP cyclohydrolase I activity(GO:0043105) |
| 0.1 | 6.7 | GO:0016573 | histone acetylation(GO:0016573) |
| 0.1 | 0.1 | GO:0032915 | positive regulation of transforming growth factor beta2 production(GO:0032915) mediolateral intercalation(GO:0060031) planar cell polarity pathway involved in gastrula mediolateral intercalation(GO:0060775) |
| 0.1 | 0.5 | GO:0040032 | post-embryonic body morphogenesis(GO:0040032) |
| 0.1 | 0.7 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
| 0.1 | 0.2 | GO:0016267 | O-glycan processing, core 1(GO:0016267) |
| 0.1 | 1.0 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
| 0.1 | 0.6 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
| 0.1 | 1.2 | GO:0016180 | snRNA processing(GO:0016180) |
| 0.1 | 0.1 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
| 0.1 | 0.6 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
| 0.1 | 0.4 | GO:0090527 | actin filament reorganization(GO:0090527) |
| 0.1 | 0.6 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
| 0.1 | 0.7 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
| 0.1 | 1.3 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
| 0.1 | 0.5 | GO:0060965 | negative regulation of gene silencing by miRNA(GO:0060965) |
| 0.1 | 0.3 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
| 0.1 | 1.0 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
| 0.1 | 0.7 | GO:0097201 | negative regulation of transcription from RNA polymerase II promoter in response to stress(GO:0097201) |
| 0.1 | 1.1 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
| 0.1 | 0.2 | GO:0046626 | regulation of insulin receptor signaling pathway(GO:0046626) |
| 0.1 | 0.9 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
| 0.1 | 0.2 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 0.1 | 0.8 | GO:0045048 | protein insertion into ER membrane(GO:0045048) |
| 0.1 | 0.4 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
| 0.1 | 0.4 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
| 0.1 | 0.5 | GO:0050957 | equilibrioception(GO:0050957) |
| 0.1 | 1.8 | GO:0045742 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) |
| 0.1 | 2.4 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
| 0.1 | 0.4 | GO:1903786 | mycotoxin catabolic process(GO:0043387) aflatoxin catabolic process(GO:0046223) organic heteropentacyclic compound catabolic process(GO:1901377) regulation of glutathione biosynthetic process(GO:1903786) positive regulation of glutathione biosynthetic process(GO:1903788) |
| 0.1 | 2.2 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
| 0.1 | 0.6 | GO:0097240 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
| 0.0 | 0.6 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
| 0.0 | 0.6 | GO:2000780 | negative regulation of double-strand break repair(GO:2000780) |
| 0.0 | 0.2 | GO:0042335 | cuticle development(GO:0042335) |
| 0.0 | 1.1 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
| 0.0 | 0.1 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
| 0.0 | 0.1 | GO:0000710 | meiotic mismatch repair(GO:0000710) |
| 0.0 | 0.2 | GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
| 0.0 | 0.5 | GO:0009629 | response to gravity(GO:0009629) |
| 0.0 | 1.4 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
| 0.0 | 0.2 | GO:0019856 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
| 0.0 | 0.3 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
| 0.0 | 0.4 | GO:0006265 | DNA topological change(GO:0006265) |
| 0.0 | 0.4 | GO:0007249 | I-kappaB kinase/NF-kappaB signaling(GO:0007249) |
| 0.0 | 0.3 | GO:0042446 | hormone biosynthetic process(GO:0042446) |
| 0.0 | 0.5 | GO:0021527 | spinal cord association neuron differentiation(GO:0021527) |
| 0.0 | 1.8 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
| 0.0 | 0.4 | GO:0032310 | prostaglandin secretion(GO:0032310) |
| 0.0 | 0.9 | GO:0042177 | negative regulation of protein catabolic process(GO:0042177) |
| 0.0 | 0.1 | GO:0003064 | regulation of heart rate by hormone(GO:0003064) |
| 0.0 | 1.3 | GO:2000178 | negative regulation of neural precursor cell proliferation(GO:2000178) |
| 0.0 | 1.7 | GO:0048268 | clathrin coat assembly(GO:0048268) |
| 0.0 | 1.6 | GO:0090383 | phagosome acidification(GO:0090383) |
| 0.0 | 1.4 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 0.0 | 1.7 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
| 0.0 | 1.1 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
| 0.0 | 0.2 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 0.0 | 1.5 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
| 0.0 | 0.2 | GO:0035358 | regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035358) positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
| 0.0 | 0.2 | GO:0048341 | paraxial mesoderm formation(GO:0048341) |
| 0.0 | 1.1 | GO:0006298 | mismatch repair(GO:0006298) |
| 0.0 | 0.1 | GO:0006423 | cysteinyl-tRNA aminoacylation(GO:0006423) |
| 0.0 | 0.2 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
| 0.0 | 0.7 | GO:0000732 | strand displacement(GO:0000732) |
| 0.0 | 0.3 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
| 0.0 | 3.8 | GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
| 0.0 | 0.1 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
| 0.0 | 0.5 | GO:0030952 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) establishment or maintenance of cytoskeleton polarity(GO:0030952) |
| 0.0 | 0.5 | GO:0060056 | mammary gland involution(GO:0060056) |
| 0.0 | 0.6 | GO:2000059 | negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
| 0.0 | 0.6 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
| 0.0 | 0.2 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
| 0.0 | 0.6 | GO:0030091 | protein repair(GO:0030091) |
| 0.0 | 0.5 | GO:2000291 | regulation of myoblast proliferation(GO:2000291) |
| 0.0 | 0.0 | GO:0072553 | terminal button organization(GO:0072553) |
| 0.0 | 0.3 | GO:0002088 | lens development in camera-type eye(GO:0002088) |
| 0.0 | 2.1 | GO:0032508 | DNA duplex unwinding(GO:0032508) |
| 0.0 | 0.4 | GO:0010265 | SCF complex assembly(GO:0010265) |
| 0.0 | 0.1 | GO:0002276 | basophil activation involved in immune response(GO:0002276) |
| 0.0 | 0.1 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
| 0.0 | 0.5 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
| 0.0 | 0.6 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
| 0.0 | 0.6 | GO:0045793 | positive regulation of cell size(GO:0045793) |
| 0.0 | 0.2 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
| 0.0 | 0.6 | GO:0014020 | primary neural tube formation(GO:0014020) |
| 0.0 | 0.2 | GO:0003073 | regulation of systemic arterial blood pressure(GO:0003073) |
| 0.0 | 0.1 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
| 0.0 | 0.3 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
| 0.0 | 0.2 | GO:0001767 | establishment of lymphocyte polarity(GO:0001767) |
| 0.0 | 1.4 | GO:0015914 | phospholipid transport(GO:0015914) |
| 0.0 | 0.4 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
| 0.0 | 1.5 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
| 0.0 | 1.3 | GO:0036150 | phosphatidylserine acyl-chain remodeling(GO:0036150) |
| 0.0 | 1.4 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
| 0.0 | 0.4 | GO:0052405 | negative regulation by host of symbiont molecular function(GO:0052405) |
| 0.0 | 0.4 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
| 0.0 | 0.2 | GO:1904781 | positive regulation of protein localization to centrosome(GO:1904781) |
| 0.0 | 0.7 | GO:0000726 | non-recombinational repair(GO:0000726) |
| 0.0 | 7.3 | GO:0038096 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis(GO:0002433) Fc-gamma receptor signaling pathway involved in phagocytosis(GO:0038096) |
| 0.0 | 0.8 | GO:0050995 | negative regulation of lipid catabolic process(GO:0050995) |
| 0.0 | 0.4 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
| 0.0 | 1.4 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
| 0.0 | 0.1 | GO:0032918 | polyamine acetylation(GO:0032917) spermidine acetylation(GO:0032918) |
| 0.0 | 0.3 | GO:0072642 | interferon-alpha secretion(GO:0072642) regulation of interferon-alpha secretion(GO:1902739) positive regulation of interferon-alpha secretion(GO:1902741) |
| 0.0 | 1.9 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
| 0.0 | 5.2 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
| 0.0 | 0.2 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
| 0.0 | 0.1 | GO:0021503 | neural fold bending(GO:0021503) |
| 0.0 | 0.2 | GO:0090669 | telomerase RNA stabilization(GO:0090669) |
| 0.0 | 0.8 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
| 0.0 | 0.2 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
| 0.0 | 1.9 | GO:0031640 | killing of cells of other organism(GO:0031640) disruption of cells of other organism(GO:0044364) |
| 0.0 | 0.1 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
| 0.0 | 0.2 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
| 0.0 | 0.2 | GO:0009597 | detection of virus(GO:0009597) |
| 0.0 | 3.0 | GO:0030049 | muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) |
| 0.0 | 0.3 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
| 0.0 | 0.5 | GO:0042048 | olfactory behavior(GO:0042048) |
| 0.0 | 0.3 | GO:0071763 | nuclear membrane organization(GO:0071763) |
| 0.0 | 1.0 | GO:1904667 | negative regulation of ubiquitin protein ligase activity(GO:1904667) |
| 0.0 | 0.7 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
| 0.0 | 0.4 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
| 0.0 | 2.3 | GO:0006333 | chromatin assembly or disassembly(GO:0006333) |
| 0.0 | 1.1 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
| 0.0 | 0.4 | GO:0035313 | wound healing, spreading of epidermal cells(GO:0035313) |
| 0.0 | 0.5 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
| 0.0 | 1.1 | GO:0006342 | chromatin silencing(GO:0006342) |
| 0.0 | 0.4 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
| 0.0 | 0.5 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
| 0.0 | 0.2 | GO:0055129 | L-proline biosynthetic process(GO:0055129) |
| 0.0 | 0.8 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
| 0.0 | 0.3 | GO:0010624 | regulation of Schwann cell proliferation(GO:0010624) negative regulation of Schwann cell proliferation(GO:0010626) Schwann cell proliferation(GO:0014010) |
| 0.0 | 0.7 | GO:0016241 | regulation of macroautophagy(GO:0016241) |
| 0.0 | 1.7 | GO:0051646 | mitochondrion localization(GO:0051646) |
| 0.0 | 0.3 | GO:0032006 | regulation of TOR signaling(GO:0032006) |
| 0.0 | 0.5 | GO:0060065 | uterus development(GO:0060065) |
| 0.0 | 0.4 | GO:0060155 | platelet dense granule organization(GO:0060155) |
| 0.0 | 0.8 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
| 0.0 | 0.1 | GO:1904397 | negative regulation of neuromuscular junction development(GO:1904397) |
| 0.0 | 0.6 | GO:0008340 | determination of adult lifespan(GO:0008340) |
| 0.0 | 1.5 |